Showing 1 - 10 of 3,662
We study the moral hazard effects of the drug copayment threshold in Finland using detailed prescription drug purchase data. The analysis reveals that the average drug costs increase discontinuously by 17% at the threshold above which out-of-pocket drug costs decrease substantially. Our results...
Persistent link: https://www.econbiz.de/10014347101
We study the moral hazard effects of the drug copayment threshold in Finland using detailed prescription drug purchase data. The analysis reveals that the average drug costs increase discontinuously by 17% at the threshold above which out-of-pocket drug costs decrease substantially. Our results...
Persistent link: https://www.econbiz.de/10014347995
The United States is experiencing an epidemic of opioid abuse. In response, many states have increased access to naloxone, a drug that can save lives when administered during an overdose. However, naloxone access may unintentionally increase opioid abuse through two channels: (1) reducing the...
Persistent link: https://www.econbiz.de/10011853131
Persistent link: https://www.econbiz.de/10013463129
Persistent link: https://www.econbiz.de/10000638533
Persistent link: https://www.econbiz.de/10003749989
Persistent link: https://www.econbiz.de/10000973683
Persistent link: https://www.econbiz.de/10001017162
Persistent link: https://www.econbiz.de/10014339440
Persistent link: https://www.econbiz.de/10014228816